Perioperative pembrolizumab can improve OS when combined with neoadjuvant chemotherapy in patients with high risk, ...
HER2 and HER3 expression in ovarian cancer: Evolution across chemotherapy exposure and implications for targeted therapies. Median PFS by BIRC, month (95% CI) 5.49 (4.93,6.64) 2.73 (1.94,3.75) Median ...
Impact of body mass index on immunotherapy outcomes and complications in solid tumor patients: A real-world evidence analysis. Median progression-free survival, mo (95% CI) 4.6 (3.4, 7.4) 4.6 (3.6, ...
The Athletic has live coverage of the 2026 Australian Open men’s singles final between Carlos Alcaraz and Novak Djokovic. The No. 5 seed prevailed over the No. 1 seed in a tight, serve-dominated match ...
The Nature Index 2025 Research Leaders — previously known as Annual Tables — reveal the leading institutions and countries/territories in the natural and health sciences, according to their output in ...
In the phase 3 EMBARK trial, enzalutamide plus leuprolide and enzalutamide monotherapy were associated with longer metastasis-free survival than leuprolide alone among patients with biochemically ...
Shanghai Junshi Biosciences Co., Ltd (Junshi Biosciences, HKEX: 1877; SSE: 688180), a leading innovation-driven ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results